Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3receptor antagonist GSK1144814 in alcohol-intoxicated volunteers

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

(2011) Emiliangelo Ratti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429

(2011) Jesse R. Schank et al.   PSYCHOPHARMACOLOGY

Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers

(2010) Remco W. M. Zoethout et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

NK-3 receptor antagonism prevents behavioral sensitization to cocaine: a role of glycogen synthase kinase-3 in the nucleus accumbens

(2010) Chinwe A. Nwaneshiudu et al.   JOURNAL OF NEUROCHEMISTRY

Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice

(2010) Annika Thorsell et al.   PSYCHOPHARMACOLOGY

Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis

(2009) J. Koskinen et al.   ACTA PSYCHIATRICA SCANDINAVICA

Neuronal pathways linking substance P to drug addiction and stress

(2009) K.G. Commons   BRAIN RESEARCH

Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers

(2009) Remco W. M. Zoethout et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Disposition and Metabolism of Radiolabeled Casopitant in Humans

(2009) M. Pellegatti et al.   DRUG METABOLISM AND DISPOSITION

Tachykinin receptor antagonists in clinical trials

(2009) Laura Quartara et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Susceptibility Locus in Neurokinin-1 Receptor Gene Associated with Alcohol Dependence

(2009) Chamindi Seneviratne et al.   NEUROPSYCHOPHARMACOLOGY

The Tachykinin Receptor 3 Is Associated With Alcohol and Cocaine Dependence

(2008) Tatiana Foroud et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol

(2008) M. Liem-Moolenaar et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A 2,3 selective agonist, in comparison with lorazepam in healthy volunteers

(2008) SL de Haas et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

(2008) D. T. George et al.   SCIENCE